Cargando…

Integrative proteomics highlight presynaptic alterations and c-Jun misactivation as convergent pathomechanisms in ALS

Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease mainly affecting upper and lower motoneurons. Several functionally heterogeneous genes have been associated with the familial form of this disorder (fALS), depicting an extremely complex pathogenic landscape. This heterogeneity...

Descripción completa

Detalles Bibliográficos
Autores principales: Aly, Amr, Laszlo, Zsofia I., Rajkumar, Sandeep, Demir, Tugba, Hindley, Nicole, Lamont, Douglas J., Lehmann, Johannes, Seidel, Mira, Sommer, Daniel, Franz-Wachtel, Mirita, Barletta, Francesca, Heumos, Simon, Czemmel, Stefan, Kabashi, Edor, Ludolph, Albert, Boeckers, Tobias M., Henstridge, Christopher M., Catanese, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412488/
https://www.ncbi.nlm.nih.gov/pubmed/37488208
http://dx.doi.org/10.1007/s00401-023-02611-y
_version_ 1785086917836013568
author Aly, Amr
Laszlo, Zsofia I.
Rajkumar, Sandeep
Demir, Tugba
Hindley, Nicole
Lamont, Douglas J.
Lehmann, Johannes
Seidel, Mira
Sommer, Daniel
Franz-Wachtel, Mirita
Barletta, Francesca
Heumos, Simon
Czemmel, Stefan
Kabashi, Edor
Ludolph, Albert
Boeckers, Tobias M.
Henstridge, Christopher M.
Catanese, Alberto
author_facet Aly, Amr
Laszlo, Zsofia I.
Rajkumar, Sandeep
Demir, Tugba
Hindley, Nicole
Lamont, Douglas J.
Lehmann, Johannes
Seidel, Mira
Sommer, Daniel
Franz-Wachtel, Mirita
Barletta, Francesca
Heumos, Simon
Czemmel, Stefan
Kabashi, Edor
Ludolph, Albert
Boeckers, Tobias M.
Henstridge, Christopher M.
Catanese, Alberto
author_sort Aly, Amr
collection PubMed
description Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease mainly affecting upper and lower motoneurons. Several functionally heterogeneous genes have been associated with the familial form of this disorder (fALS), depicting an extremely complex pathogenic landscape. This heterogeneity has limited the identification of an effective therapy, and this bleak prognosis will only improve with a greater understanding of convergent disease mechanisms. Recent evidence from human post-mortem material and diverse model systems has highlighted the synapse as a crucial structure actively involved in disease progression, suggesting that synaptic aberrations might represent a shared pathological feature across the ALS spectrum. To test this hypothesis, we performed the first comprehensive analysis of the synaptic proteome from post-mortem spinal cord and human iPSC-derived motoneurons carrying mutations in the major ALS genes. This integrated approach highlighted perturbations in the molecular machinery controlling vesicle release as a shared pathomechanism in ALS. Mechanistically, phosphoproteomic analysis linked the presynaptic vesicular phenotype to an accumulation of cytotoxic protein aggregates and to the pro-apoptotic activation of the transcription factor c-Jun, providing detailed insights into the shared pathobiochemistry in ALS. Notably, sub-chronic treatment of our iPSC-derived motoneurons with the fatty acid docosahexaenoic acid exerted a neuroprotective effect by efficiently rescuing the alterations revealed by our multidisciplinary approach. Together, this study provides strong evidence for the central and convergent role played by the synaptic microenvironment within the ALS spinal cord and highlights a potential therapeutic target that counteracts degeneration in a heterogeneous cohort of human motoneuron cultures. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00401-023-02611-y.
format Online
Article
Text
id pubmed-10412488
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-104124882023-08-11 Integrative proteomics highlight presynaptic alterations and c-Jun misactivation as convergent pathomechanisms in ALS Aly, Amr Laszlo, Zsofia I. Rajkumar, Sandeep Demir, Tugba Hindley, Nicole Lamont, Douglas J. Lehmann, Johannes Seidel, Mira Sommer, Daniel Franz-Wachtel, Mirita Barletta, Francesca Heumos, Simon Czemmel, Stefan Kabashi, Edor Ludolph, Albert Boeckers, Tobias M. Henstridge, Christopher M. Catanese, Alberto Acta Neuropathol Original Paper Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease mainly affecting upper and lower motoneurons. Several functionally heterogeneous genes have been associated with the familial form of this disorder (fALS), depicting an extremely complex pathogenic landscape. This heterogeneity has limited the identification of an effective therapy, and this bleak prognosis will only improve with a greater understanding of convergent disease mechanisms. Recent evidence from human post-mortem material and diverse model systems has highlighted the synapse as a crucial structure actively involved in disease progression, suggesting that synaptic aberrations might represent a shared pathological feature across the ALS spectrum. To test this hypothesis, we performed the first comprehensive analysis of the synaptic proteome from post-mortem spinal cord and human iPSC-derived motoneurons carrying mutations in the major ALS genes. This integrated approach highlighted perturbations in the molecular machinery controlling vesicle release as a shared pathomechanism in ALS. Mechanistically, phosphoproteomic analysis linked the presynaptic vesicular phenotype to an accumulation of cytotoxic protein aggregates and to the pro-apoptotic activation of the transcription factor c-Jun, providing detailed insights into the shared pathobiochemistry in ALS. Notably, sub-chronic treatment of our iPSC-derived motoneurons with the fatty acid docosahexaenoic acid exerted a neuroprotective effect by efficiently rescuing the alterations revealed by our multidisciplinary approach. Together, this study provides strong evidence for the central and convergent role played by the synaptic microenvironment within the ALS spinal cord and highlights a potential therapeutic target that counteracts degeneration in a heterogeneous cohort of human motoneuron cultures. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00401-023-02611-y. Springer Berlin Heidelberg 2023-07-24 2023 /pmc/articles/PMC10412488/ /pubmed/37488208 http://dx.doi.org/10.1007/s00401-023-02611-y Text en © The Author(s) 2023, corrected publication 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Paper
Aly, Amr
Laszlo, Zsofia I.
Rajkumar, Sandeep
Demir, Tugba
Hindley, Nicole
Lamont, Douglas J.
Lehmann, Johannes
Seidel, Mira
Sommer, Daniel
Franz-Wachtel, Mirita
Barletta, Francesca
Heumos, Simon
Czemmel, Stefan
Kabashi, Edor
Ludolph, Albert
Boeckers, Tobias M.
Henstridge, Christopher M.
Catanese, Alberto
Integrative proteomics highlight presynaptic alterations and c-Jun misactivation as convergent pathomechanisms in ALS
title Integrative proteomics highlight presynaptic alterations and c-Jun misactivation as convergent pathomechanisms in ALS
title_full Integrative proteomics highlight presynaptic alterations and c-Jun misactivation as convergent pathomechanisms in ALS
title_fullStr Integrative proteomics highlight presynaptic alterations and c-Jun misactivation as convergent pathomechanisms in ALS
title_full_unstemmed Integrative proteomics highlight presynaptic alterations and c-Jun misactivation as convergent pathomechanisms in ALS
title_short Integrative proteomics highlight presynaptic alterations and c-Jun misactivation as convergent pathomechanisms in ALS
title_sort integrative proteomics highlight presynaptic alterations and c-jun misactivation as convergent pathomechanisms in als
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412488/
https://www.ncbi.nlm.nih.gov/pubmed/37488208
http://dx.doi.org/10.1007/s00401-023-02611-y
work_keys_str_mv AT alyamr integrativeproteomicshighlightpresynapticalterationsandcjunmisactivationasconvergentpathomechanismsinals
AT laszlozsofiai integrativeproteomicshighlightpresynapticalterationsandcjunmisactivationasconvergentpathomechanismsinals
AT rajkumarsandeep integrativeproteomicshighlightpresynapticalterationsandcjunmisactivationasconvergentpathomechanismsinals
AT demirtugba integrativeproteomicshighlightpresynapticalterationsandcjunmisactivationasconvergentpathomechanismsinals
AT hindleynicole integrativeproteomicshighlightpresynapticalterationsandcjunmisactivationasconvergentpathomechanismsinals
AT lamontdouglasj integrativeproteomicshighlightpresynapticalterationsandcjunmisactivationasconvergentpathomechanismsinals
AT lehmannjohannes integrativeproteomicshighlightpresynapticalterationsandcjunmisactivationasconvergentpathomechanismsinals
AT seidelmira integrativeproteomicshighlightpresynapticalterationsandcjunmisactivationasconvergentpathomechanismsinals
AT sommerdaniel integrativeproteomicshighlightpresynapticalterationsandcjunmisactivationasconvergentpathomechanismsinals
AT franzwachtelmirita integrativeproteomicshighlightpresynapticalterationsandcjunmisactivationasconvergentpathomechanismsinals
AT barlettafrancesca integrativeproteomicshighlightpresynapticalterationsandcjunmisactivationasconvergentpathomechanismsinals
AT heumossimon integrativeproteomicshighlightpresynapticalterationsandcjunmisactivationasconvergentpathomechanismsinals
AT czemmelstefan integrativeproteomicshighlightpresynapticalterationsandcjunmisactivationasconvergentpathomechanismsinals
AT kabashiedor integrativeproteomicshighlightpresynapticalterationsandcjunmisactivationasconvergentpathomechanismsinals
AT ludolphalbert integrativeproteomicshighlightpresynapticalterationsandcjunmisactivationasconvergentpathomechanismsinals
AT boeckerstobiasm integrativeproteomicshighlightpresynapticalterationsandcjunmisactivationasconvergentpathomechanismsinals
AT henstridgechristopherm integrativeproteomicshighlightpresynapticalterationsandcjunmisactivationasconvergentpathomechanismsinals
AT catanesealberto integrativeproteomicshighlightpresynapticalterationsandcjunmisactivationasconvergentpathomechanismsinals